NTP DEA review
This article was originally published in The Rose Sheet
Executive Summary
National Toxicology Program will evaluate diethanalomine for listing in the 11th Report on Carcinogens at an NTP Board of Scientific Counselors RoC Subcommittee meeting Nov. 19-20 in Bethesda, Md. DEA is among 10 chemicals scheduled for peer review, and NTP will provide opportunity for public comment on each of the substances during the meeting, agency notes. DEA, an ingredient widely used in personal care products, was nominated for listing in 2001 (1"The Rose Sheet" July 30, 2001, In Brief). NTP released a draft background document on DEA earlier this year (2"The Rose Sheet" June 3, 2002, p. 4)...
You may also be interested in...
NTP lead review
National Toxicology Program to review lead and lead compounds for listing in "11th Report on Carcinogens" at an NTP Board of Scientific Counselors RoC subcommittee meeting Oct. 14-15 in Washington, D.C. agency announces in Aug. 8 Federal Register 1notice. Lead and lead compounds, which are used in some traditional cosmetics, are among seven substances nominated for peer review during the meeting. NTP will provide opportunity for public comment on each of the chemicals at that time, agency notes. The group is the second set to be reviewed for listing; NTP reviewed 10 substances, including DEA, at a public meeting in November (2"The Rose Sheet" Sept. 23, 2002, In Brief)...
DEA Cosmetics Use, Carcinogenicity Potential Explored In NTP Report
Consumer exposure to diethanolamine appears to be widespread with dermal exposure to personal care products serving as the "most probable route," the National Toxicology Program states in a background draft document for the 11th "Report on Carcinogens.
DEA
National Toxicology Program to review diethanolamine for listing in "11th Report on Carcinogens," slated for publication in 2004, NTP announces in July 24 Federal Register notice. Nominated ingredients must be "known to be human carcinogens" or "reasonably anticipated to be human carcinogens" to qualify for listing. NTP will accept comments concerning DEA until Sept. 24. DEA and its esters are used in more than 4,000 personal care products including bubble bath, shampoo and conditioner. Ingredient has been nominated for listing under California Prop 65 and is topic of safety assessment underway at FDA's Office of Cosmetics & Colors